A study of a catheter for atrial fibrillation ablation
Part of Heart & circulation clinical trials.
This registry is for people with atrial fibrillation who are planning to have a heart ablation procedure using a specific catheter called TactiFlex SE. It aims to collect information about how well the catheter works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your doctor has said you are a good candidate for ablation to treat your atrial fibrillation.
- You are planning to have an ablation with the TactiFlex SE catheter (made by Abbott).
- You are 18 years old or older.
- You are not currently in another heart device or drug study.
- You are willing to come in for all follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study tracks results after a heart ablation procedure used to treat atrial fibrillation (an irregular heart rhythm). You may be asked to help by consenting and following the study plan so the researchers can better understand what happens after ablations.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
This study tests a new catheter system, called Varipulse, to see if it's safe and effective for treating atrial fibrillation (AF), a heart rhythm problem. People with short-lasting AF who haven't been helped by medication may be able to join.
This study follows people after a procedure called catheter ablation to treat atrial fibrillation (an irregular heart rhythm). It aims to learn which factors help predict outcomes, so future care can be better tailored.
This study tests a new device (FARAFLEX) that uses pulsed field energy to treat atrial fibrillation (AFib). You may qualify if you have persistent or paroxysmal AFib symptoms and have not had a prior ablation.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.